Novavax
NVAX
#5728
Rank
S$1.64 B
Marketcap
S$9.97
Share price
-3.02%
Change (1 day)
20.39%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2026 (TTM): -S$0.29 Billion

According to Novavax's latest financial reports the company's current earnings are S$0.41 Billion. In 2025 the company made an earning of S$0.60 Billion, an increase over its 2024 earnings that were of -S$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.29 Billion-148.09%
2025 S$0.60 B-396.87%
2024 -S$0.21 Billion-70.39%
2023 -S$0.69 Billion-16.59%
2022 -S$0.82 Billion-62.58%
2021 -S$2.19 Billion320.54%
2020 -S$0.53 Billion234.22%
2019 -S$0.16 Billion-30.17%
2018 -S$0.23 Billion1.69%
2017 -S$0.22 Billion-36.44%
2016 -S$0.35 Billion70.4%
2015 -S$0.21 Billion89.27%
2014 -S$0.11 Billion59.83%
2013 -S$66.89 Million81.9%
2012 -S$36.77 Million50.33%
2011 -S$24.46 Million
2009 -S$48.27 Million8.8%
2008 -S$44.37 Million18.01%
2007 -S$37.6 Million18.33%
2006 -S$31.78 Million168.31%
2005 -S$11.85 Million-62.51%
2004 -S$31.59 Million52.4%
2003 -S$20.73 Million-28.21%
2002 -S$28.88 Million
2000 -S$16.46 Million177%
1999 -S$5.94 Million-11.54%
1998 -S$6.72 Million10.64%
1997 -S$6.07 Million-9.62%
1996 -S$6.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
S$16.32 B-5,758.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$8.99 B-3,218.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$19.48 B-6,853.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$9.23 B-3,302.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-S$0.17 Billion-41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.43 Billion 45.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$0.19 B-167.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-S$10.62 Million-96.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$0.46 Billion 58.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-S$0.26 Billion-12.90%๐Ÿ‡บ๐Ÿ‡ธ USA